ERF — Eurofins Scientific SE Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Eurofins Scientific SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	272	694	1,057	780	423
Depreciation
Amortisation
Non-Cash Items	69.6	143	227	12.2	135
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-159	-143	-315	-265	-204
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	678	1,224	1,512	1,136	1,018
Capital Expenditures	-425	-356	-506	-660	-550
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-115	-170	-515	-196	-131
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities	-540	-525	-1,021	-856	-681
Financing Cash Flow Items	-462	-105	-206	-503	-308
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-342	-48.6	-910	-311	414
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-201	616	-396	-31.8	738